| Balance Sheets | 2026-06-30 | 2026-03-31 | 2025-12-31 | |
|---|---|---|---|---|
| Cash | 699,573 | 854,833 | - | |
| Prepaid expense and insurance | 73,105 | 76,410 | - | |
| Total current assets | 772,678 | 931,243 | - | |
| Deferred offering costs | 0 | 0 | - | |
| Long-term prepaid insurance | 39,601 | 56,629 | - | |
| Deferred offering costs-non-current asset | - | - | 139,598 | |
| Cash held in trust account | 170,942,950 | 169,419,562 | - | |
| Total assets | 171,755,229 | 170,407,434 | 139,598 | |
| Accounts payable and accrued expenses | 183,305 | 97,863 | - | |
| Accrued expenses | - | - | 23,592 | |
| Offering costs payable | 132,274 | 134,029 | - | |
| Accrued offering costs | - | - | 83,223 | |
| Short-term loan | 63,207 | 84,634 | - | |
| Promissory note related party | - | - | 75,806 | |
| Promissory note - related party | 0 | 0 | - | |
| Total current liabilities | 378,786 | 316,526 | 182,621 | |
| Deferred underwriting fee payable | 7,115,000 | 7,115,000 | - | |
| Total liabilities | 7,493,786 | 7,431,526 | 182,621 | |
| Class a ordinary shares subject to possible redemption, 0.0001 par value 16,850,000 and no shares at a redemption value of 10.14 and 0 per share as of june 30, 2026 and december 31, 2025, respectively | 170,942,950 | 169,419,562 | - | |
| Common stock value-Common Class A | 44 | 44 | 0 | |
| Common stock value-Common Class B | 562 | 562 | 575 | |
| Stock subscription receivable from sponsor | - | -21,960 | - | |
| Additional paid-in capital | 0 | 0 | 24,425 | |
| Accumulated deficit | -6,682,113 | -6,422,300 | -68,023 | |
| Total shareholders deficit | -6,681,507 | -6,443,654 | -43,023 | |
| Total liabilities, class a ordinary shares subject to possible redemption and shareholders deficit | 171,755,229 | 170,407,434 | 139,598 | |
Iris Acquisition Corp II (IRAB-UN)
Iris Acquisition Corp II (IRAB-UN)